Skip to search formSkip to main contentSkip to account menu

LY517717

Known as: LY 517717, LY-517717 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

GlycinePiperazines
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Investigational anticoagulants for hematological conditions: a new generation of therapies
Introduction: The introduction of novel anticoagulants has had contrasting effects on the agents in the pipeline, fueling the… 
Review
2011
Review
2011
Optimization of Anticoagulation with Warfarin for Stroke Prevention: Pharmacogenetic Considerations
Warfarin is a cornerstone of oral anticoagulation for stroke prevention. Anticoagulation with warfarin in patients with atrial… 
Review
2010
Review
2010
Reducing Human Error in Checking Concomitant Medications
Subject safety and scientific validity require sites to avoid enrolling subjects who are taking certain “concomitant” medications… 
Review
2009
Review
2009
Factor Xa inhibitors
Summary Oral factor Xa (FXa) inhibitors are a promising alternative to current anticoagulants. This paper reviews the latest… 
Review
2009
Review
2009
Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review
Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a major cause of morbidity and… 
Review
2007
Review
2007
Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review
Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a major cause of morbidity and… 
2007
2007
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the… 
2007
2007
Gateways to clinical trials.
12B75, 274150; Abacavir sulfate/lamivudine, Abatacept, Ad2/HIF-1alpha, Adalimumab, Adefovir, Adefovir dipivoxil, AGN-201904-Z… 
2007
2007
LY 517717 vs enoxaparin for VTE prophylaxis after surgery
  • 2007
  • Corpus ID: 195118277
Review
2006
Review
2006
Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery.
Current anticoagulant provision is dominated by parenteral heparin and oral warfarin, which act by inhibiting several steps of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)